Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AutoCanada Acquires Two Colorworks Autobody Collision Repair Facilities in Coquitlam and Port Coquitlam

AutoCanada Acquires Two Colorworks Autobody Collision Repair Facilities in Coquitlam and Port Coquitlam

MT newswireMT newswire2026/10/08 12:36

08:36 AM EDT, 10/08/2026 (MT Newswires) -- AutoCanada (ACQ.TO) completed the acquisition of two Colorworks Autobody collision repair facilities in Coquitlam and Port Coquitlam, British Columbia, adding approximately 12,100 square feet of collision repair capacity, it said Thursday. The locations collectively hold certifications covering Volvo, Nissan, Kia, Hyundai, Honda, Acura, Genesis, Ford, Stellantis, and Toyota, said the company.

08:36 AM EDT, 10/08/2026 (MT Newswires) -- AutoCanada (ACQ.TO) completed the acquisition of two Colorworks Autobody collision repair facilities in Coquitlam and Port Coquitlam, British Columbia, adding approximately 12,100 square feet of collision repair capacity, it said Thursday. The locations collectively hold certifications covering Volvo, Nissan, Kia, Hyundai, Honda, Acura, Genesis, Ford, Stellantis, and Toyota, said the company.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss